A motif within the N-terminal domain of TSP-1 specifically promotes the proangiogenic activity of endothelial colony-forming cells

Thrombospondin-1 (TSP-1) gives rise to fragments that have both pro- and anti-angiogenic effects in vitro and in vivo. the TSP-HepI peptide (2.3 kDa), located in the N-terminal domain of TSP-1, has proangiogenic effects on endothelial cells. We have previously shown that TSP-1 itself exhibits a dual effect on endothelial colony-forming cells (ECFC) by enhancing their adhesion through its TSP-HepI fragment while reducing their proliferation and differentiation into vascular tubes (tubulogenesis) in vitro. This effect is likely mediated through CD47 binding to the TSP-1 C-terminal domain. Here we investigated the effect of TSP-HepI peptide on the angiogenic properties of ECFC in vitro and in vivo. TSP-HepI peptide potentiated FGF-2-induced neovascularisation by enhancing ECFC chemotaxis and tubulogenesis in a Matrigel plug assay. ECFC exposure to 20 mu g/mL of TSP-HepI peptide for 18 h enhanced cell migration (p < 0.001 versus VEGF exposure), upregulated alpha 6-integrin expression, and enhanced their cell adhesion to activated endothelium under physiological shear stress conditions at levels comparable to those of SDF-1 alpha. the adhesion enhancement appeared to be mediated by the heparan sulfate proteoglycan (HSPG) syndecan-4, as ECFC adhesion was significantly reduced by a syndecan-4-neutralising antibody. ECFC migration and tubulogenesis were stimulated neither by a TSP-HepI peptide with a modified heparin-binding site (S/TSP-HepI) nor when the glycosaminoglycans (GAGS) moieties were removed from the ECFC surface by enzymatic treatment. Ex vivo TSP-HepI priming could potentially serve to enhance the effectiveness of therapeutic neovascularisation with ECFC. (C) 2012 Elsevier Inc. All rights reserved.Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Groupe d'Etude et de Recherches sur l'Hemostase (GEHT)Region Ile-de-France (CORDDIM)Leducq TransAtlantic Network of ExcellenceUniv Estado Rio de Janeiro, Dept Biol Celular, Lab Biol Celula Endotelial & Angiogenese LabAngio, Inst Biol Roberto Alcantara Gomes, BR-20550011 Rio de Janeiro, RJ, BrazilINSERM, U765, Paris, FranceUniv Paris 05, Paris, FranceUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, BrazilUniv Fed Rio de Janeiro, Inst Ciencias Biomed, Rio de Janeiro, RJ, BrazilHop Europeen Georges Pompidou, AP HP, Dept Haematol, Paris, FranceINSERM, Paris Cardiovasc Res Ctr, U970, Paris, FranceUniversidade Federal de São Paulo, Escola Paulista Med, Dept Biofis, São Paulo, BrazilLeducq TransAtlantic Network of Excellence: 04CVD01-LENALeducq TransAtlantic Network of Excellence: 04CVD02 -LINATCNPq: E-26/110.780/2010CAPES: 629/09Web of Scienc

Severity of Retrognathia and Glossoptosis Does Not Predict Respiratory and Feeding Disorders in Pierre Robin Sequence

Pierre Robin sequence (PRS) may lead to life-threatening respiratory and feeding disorders. With the aim to analyse the association of the severities of retrognathia and glossoptosis with those of respiratory and feeding disorders, we retrospectively studied a series of 50 infants with retrognathia, glossoptosis, cleft palate, and airway obstruction. The patients were managed from birth to at least 6 years of age by a single pediatric team at the Armand Trousseau Hospital in Paris within a 12 years period (2000–2012). Retrognathia and glossoptosis were graded in the neonatal period according to a specific clinical examination. Ventilation assistance was required for 32/50 (64%) patients, and enteral feeding for 41/50 (82%). The grades of retrognathia and glossoptosis and the severity of respiratory disorders did not differ between patients with isolated PRS and syndromic PRS. Severe respiratory disorders were more common and long-lasting feeding (&gt;12 months) was more frequently required in patients with syndromic PRS compared with isolated PRS (42 vs. 13%, p = 0.04 and 42 vs. 4%, p &lt; 0.01 respectively). Using univariate analysis, neurological impairments and laryngomalacia were associated with severe respiratory disorders [Odds ratio (OR) 5.0, 95% CI 1.3–19.6; and OR 14.6, 95% CI 1.3–161.4; p &lt; 0.05] as well as with long-lasting feeding (&gt;12 months) disorders (OR 18.6, 95% CI 3.9–89.2 and OR 20.4, 95% CI 3,4–122.8; p &lt; 10−2). Syndromic SPR status was also associated with severe respiratory disorders (OR 4.9, 95% CI 1–32.5; p &lt; 0.05). Using multivariate analysis, only syndromic PRS status was predictive for severe respiratory disorders (adjusted OR 8, 95% CI 1.47–44.57; p &lt; 0.05); and only neurological impairments remained a significant risk for long lasting feeding disorders (&gt;12 months) (adjusted OR 21.72, 95% CI 3.4–138.63; p &lt; 10−2). The grades of retrognathia and glossoptosis were not predictive factors for the severity of respiratory and feeding disorders.Conclusion: In children with PRS, the severity of clinical conditions may not correlate with anatomic variables but rather with laryngeal abnormalities, neurological impairement and syndromic PRS status

Retrospective French nationwide survey of childhood aggressive vascular anomalies of bone, 1988-2009

<p>Abstract</p> <p>Objective</p> <p>To document the epidemiological, clinical, histological and radiological characteristics of aggressive vascular abnormalities of bone in children.</p> <p>Study design</p> <p>Correspondents of the French Society of Childhood Malignancies were asked to notify all cases of aggressive vascular abnormalities of bone diagnosed between January 1988 and September 2009.</p> <p>Results</p> <p>21 cases were identified; 62% of the patients were boys. No familial cases were observed, and the disease appeared to be sporadic. Mean age at diagnosis was 8.0 years [0.8-16.9 years]. Median follow-up was 3 years [0.3-17 years]. The main presenting signs were bone fracture (n = 4) and respiratory distress (n = 7), but more indolent onset was observed in 8 cases. Lung involvement, with lymphangiectasies and pleural effusion, was the most frequent form of extraosseous involvement (10/21). Bisphosphonates, alpha interferon and radiotherapy were used as potentially curative treatments. High-dose radiotherapy appeared to be effective on pleural effusion but caused major late sequelae, whereas antiangiogenic drugs like alpha interferon and zoledrenate have had a limited impact on the course of pulmonary complications. The impact of bisphosphonates and alpha interferon on bone lesions was also difficult to assess, owing to insufficient follow-up in most cases, but it was occasionally positive. Six deaths were observed and the overall 10-year mortality rate was about 30%. The prognosis depended mainly on pulmonary and spinal complications.</p> <p>Conclusion</p> <p>Aggressive vascular abnormalities of bone are extremely rare in childhood but are lifethreatening. The impact of anti-angiogenic drugs on pulmonary complications seems to be limited, but they may improve bone lesions.</p

Temporal Dynamics of Interferon Gamma Responses in Children Evaluated for Tuberculosis

BACKGROUND: Development of T-cells based-Interferon gamma (IFNgamma) assays has offered new possibilities for the diagnosis of latent tuberculosis infection (LTBI) and active disease in adults. Few studies have been performed in children, none in France. With reference to the published data on childhood TB epidemiology in the Paris and Ile de France Region, we considered it important to evaluate the performance of IGRA (QuantiFERON TB Gold In Tube(R), QF-TB-IT) in the diagnosis and the follow-up through treatment of LTBI and active TB in a cohort of French children. METHODOLOGY/PRINCIPAL FINDINGS: 131 children were recruited during a prospective and multicentre study (October 2005 and May 2007; Ethical Committee St Louis Hospital, Paris, study number 2005/32). Children were sampled at day 0, 10, 30, 60 (except Healthy Contacts, HC) and 90 for LTBI and HC, and a further day 120, and day 180 for active TB children. Median age was 7.4 years, with 91% of the children BCG vaccinated. LTBI and active TB children undergoing therapy produced significant higher IFNgamma values after 10 days of treatment (p = 0.035). In addition, IFNgamma values were significantly lower at the end of treatment compared to IFNgamma values at day 0, although the number of positive patients was not significantly different between day 0 and end of treatment. CONCLUSIONS/ SIGNIFICANCE: By following quantitative IFNgamma values in each enrolled child with LTBI or active TB and receiving treatment, we were able to detect an increase in the IFNgamma response at day 10 of treatment which might allow the confirmation of a diagnosis. In addition, a decline in IFNgamma values during treatment makes it possible for clinicians to monitor the effect of preventive or curative therapy

Deux autographes de Dudon de Saint-Quentin (1011, 1015)

Fauroux Marie. Deux autographes de Dudon de Saint-Quentin (1011, 1015). In: Bibliothèque de l'école des chartes. 1953, tome 111. pp. 229-234

Dental implant Osseointegration : ZIR-ROC clinical research : materials, operative surgery, limits and perspectives

Introduction : Depuis les premiers implants dentaires Bränemark, les techniques chirurgicales et les matériaux implantaires ont évolué. La référence en terme de matériau implantaire est le Titane. Cependant, d’autres matériaux comme le Zircone ont été proposés pour suppléer le Titane en cas d’allergie au Titane mais aussi pour améliorer la bio-intégration de l’implant dentaire et l’esthétique. Les facteurs de risques d’échec implantaire des implants en Titane incluent, entre autre, l’hygiène orale, la consommation de tabac et la mise en charge immédiate. Objectif : L’étude ZIR-ROC a donc été menée dans le but d’étudier le taux de survie de ces implants zircone après 2 ans de suivi, de recueillir des informations sur l’intégration tissulaire des implants et de rechercher les facteurs de risque d’échec des implants en Zircone. Matériel et méthode : l’étude ZIR-ROC a été menée dans le service de chirurgie orale du CHU de Montpellier sur des implants monobloc en Zircone de la société Paris Implant®. La pose de 43 implants a été déterminée pour permettre l’analyse statistique des résultats. Le forage et l’insertion des implants ont été réalisés à l’aide du système de chirurgie guidée 2ingis®. La variable principale pour évaluer l’ostéo-intégration des implants a été le score délivré par le Periotest®. 22 variables secondaires ont été recueillies tels que les indices gingivaux et de plaque ainsi que l’analyse rétro-alvéolaire. Les données ont été relevées juste avant la chirurgie implantaire, ainsi qu’à 1 semaine, 4 semaines, 5 mois, 1 an et 2 ans. La méthode de Kaplan-Meier, le modèle de Cox et les analyses en composantes principales ont été utilisés pour l’analyse statistique. Résultats : Tous les implants ont présenté une bonne stabilité primaire post-opératoire (valeurs du Periotest comprises entre -8 et +1 ; moyenne à -5,7). Le taux d’échec implantaire a atteint 31% après les 5 premiers mois d’ostéo-intégration. Une mobilité clinique a été observée pour les implants perdus. Les facteurs de risque décrits dans la littérature ont été retrouvés dans le modèle de Cox avec une significativité pour la consommation de tabac et d’alcool et sans significativité statistique pour la densité osseuse ou encore la mise en place d’une couronne provisoire. Par ailleurs, la présence de plaque et d’inflammation gingivale a été observée en faible quantité sur les implants en Zircone. Discussion et conclusion : Le Zircone apparaît comme un matériau biocompatible pour des implants dentaires. Les causes des échecs implantaires précoces observés sont probablement multiples et cette étude n’a pas permis de démontrer l’implication seule de la Zircone dans ces échecs. La recherche des facteurs d’échecs implantaires a conduit à évaluer la technique chirurgicale utilisée pour cette étude mais aussi le dessin de l’implant. De plus, une étude in vitro comparant des implants à base de Zircone et de Titane a été entreprise pour évaluer l’affinité de cellules souches d’origine dentaire pour les 2 matériaux.Introduction: Since first Bränemark dental implants were implanted, operative surgery and materials for implantation have evolved. Titanium was the gold standard for dental implant material. But others materials like Zirconium were studied in replacement of Titanium due to allergy, bio-integration end aesthetic reasons. Contributing risk factors of Titanium implant failure include oral hygiene, tabacco and early loading among others factors. Objective: The aim of this clinical study was to evaluate survival rate of Zircon implants after 2 years, to collect information for tissue integration of Zirconium implant and to identify risk factors for Zircon implant failure. Material and Methods: ZIR-ROC study, conducted in the Oral Surgery Departement in Montpellier University Hospital, used zircon monobloc (ZIR-ROC®) implants (Paris Implant Society®). 43 implants were required for statistical analysis. Drilling and implantation were conducted with 2ingis® surgical guide system. The Periotest® value was the first endpoint for the implant osseointegration analysis. Gingival and dental plaque indices as well as intraoral X-ray analysis were part of the 22 secondary variables. Data were collected just after implantation surgery, and then, 1 week, 4 weeks, 5 months, 1 year and 2 years after implantation. Kaplan-Meier method, Cox regression model and principal component analysis were used for statistical analysis. Results: All implants showed postoperative optimal primary stability (Periotest® values between -8 and +1; mean: -5,7). Implants failure rate reached 31 percent after the 5 initial months of osseointegration. Clinical mobility was observed for the failed implants. Risk factors published in the scientific literature were observed in the Cox regression model with significant statistical effect for tobacco and alcohol consumption but without significant statistical effect for osseous density or even temporary crown insertion. Furthermore, gingival inflammation and dental plaque presence were low on Zircon implant. Discussion and Conclusion: Zirconium remains a biocompatible material for dental implantation but there were probably many reasons for the observed early implant failures and this study could not demonstrate the only involvement of Zirconium based material. Operative surgery used in this clinical study and the design of the implants were studied for researching other risk factors. In addition, an in vitro study comparing Zirconium versus Titanium as gold standard, was conducted for testing affinity of dental stems cells on Titanium and Zirconium-based dental materials

PARTICULES LIPIDIQUES INTRAMACROPHAGIQUES RECUEILLIES PAR LAVAGE BRONCHOALVEOLAIRE (FREQUENCE ET INTERET DIAGNOSTIQUE CHEZ L'ENFANT ; ETUDE PROSPECTIVE SUR 80 ENFANTS)

LE KREMLIN-B.- PARIS 11-BU Méd (940432101) / SudocPARIS-BIUM (751062103) / SudocSudocFranceF

Prise en charge odontologique des patients immunodéprimés

Le système immunitaire est l'ensemble des mécanismes biologiques permettant à un organisme de reconnaître et tolérer le soi et reconnaître et rejeter 1 non-soi. Son bon fonctionnement est indispensable au maintien de l'intégrité de l'organisme. Les patients immunodéprimés présentent de grandes variétés étiologiques immunologiques. ils sont particulièrement sensibles aux infections qui ont comme point de départ la cavité buccale. Nous nous proposons de déterminer les modifications immunitaires qui influent sur l'état bucco 0 dentaire à travers quelques pathologies caractéristiques de désordres immuns. Le chirurgien 0 dentiste, acteur essentiel du système de soins doit être prévenu du risque infectieux majeur que ces patients développent et doit être capable d'en assurer le suivi.The immune system is the set of biological mechanisms to enable an organization to recognize and tolerate the self and recognize and reject non-self. Its proper functioning is essential to maintaining the integrity of the organization. Immunocompromised patients have largE varieties immunological etiology. They are particularly susceptible to infections that as a starting point the oral cavity. We propose to determine the immune changes that affect the oral health status through some pathologies characteristic of immune disorders. The dentist, a key player in the health care system must be notified of major infectious risk that these patients develop and be able to monitor.MONTPELLIER-BU Médecine UPM (341722108) / SudocMONTPELLIER-BU Odontologie (341722110) / SudocMONTPELLIER-BU Médecine (341722104) / SudocSudocFranceF

Automédication chez le coureur d ultra-trail (étude du North Face® Ultra-Trail du Mont-Blanc®)

MONTPELLIER-BU Pharmacie (341722105) / SudocSudocFranceF